This study was undertaken to determine whether glucocorticosteroids promote the secretion of lubricating surfactant, i.e. surface-active phospholipid (SAPL), into the joint. A standard clinical dose (100 mg) of methylprednisolone acetate (MPA) in 2.5 ml of saline was injected into the load-bearing right radiocarpal joint of five horses and 2.5 ml of saline injected into each of the contralateral joints used as controls. Synovial fluid (SF ) was aspirated from all 10 joints before injection and at intervals of 16 and 32 h after injection, and then analysed by standard methods. All test joints showed an elevated level of SAPL, the increases averaging 112% after 16 h and 76% after 32 h, which were highly significant relative to the control joints. A large increase at 16 h was also found in proteolipid as a possible further marker of surfactant release. Significant quantities of proteolipid were also found in human SF. Since intra-articular steroids can dramatically improve joint mobility in both humans and horses, it is proposed that part of the benefit may be derived from improved lubrication arising from the remarkable ability of SAPL to lubricate under high load. Other possible benefits of elevating surfactant levels in the joints include control of cartilage hydration, promotion of macrophage activity and the ability to scavenge oxygen free radicals.
S hydrocortisone was introduced in 1951 for local in the joint, where its adsorption to cartilage-necessary for boundary lubrication-can explain the intra-articular administration, glucocorticosteroids have been widely prescribed for the treatment of extreme hydrophobicity of the normal articular surface [10, 13] . Moreover, SAPL has been shown to be rheumatoid arthritis and other inflammatory arthropathies [1] . Although controversial at first [2] , these deficient on these surfaces in human hips and knees afflicted with osteoarthritis [14] . other arthropathies now include osteoarthritis, for which intra-synovial corticosteroids produce a benefi-
The foregoing arguments imply that intra-articular steroids might also promote the secretion of surfactant cial response consisting of a significant reduction of pain and tenderness of the joint [3] which can lead to in the synovial space, in which case it might lead to the administration of the mediator, i.e. SAPL, rather a dramatic short-term improvement in the mobility of the patient.
than steroids themselves, in attempting to gain the obvious clinical benefits without the side-effects. As a Much the same experience is reported in the veterinary literature where intra-articular injection of corticofirst step in this direction, this study is designed to determine whether a standard clinical dose of MPA, steroids into the afflicted joint is a common therapy for degenerative joint disease in the horse [4] . Despite which is so effective in the equine joint, promotes the secretion of SAPL (synovial surfactant). the controversial side-effects, corticosteroids, particularly methylprednisolone acetate (MPA), remain MATERIALS AND METHODS among the most effective drugs for the treatment of arthritic conditions in the equine joint [5] .
Horses The mechanism(s) of action of glucocorticosteroids Five healthy standardbred horses (mean body weight remains open to debate in both humans [1] and horses of 500 kg) with no overt symptoms of joint disease [4] , but would appear to extend beyond their potent were selected for the trials. A standard dose for an anti-inflammatory properties [6 ] , implying that they equine joint [15] of 100 mg Depomedrol (MPA) in act at a fundamental level of physiological function.
2.5 ml of saline was administered by careful intraOne of their basic properties in the lung [7] is their articular injection into the right radiocarpal joint using ability to promote the secretion of surfactant, which is aseptic technique. The same dose (2.5 ml ) of saline predominantly surface-active phospholipid (SAPL), as was injected into the left radiocarpal joint as a control. employed clinically in preventing the respiratory distress syndrome (RDS ) in the newborn [8] .
Methods There are now many studies [9-12] supporting the Samples of synovial fluid (SF ) (2 ml ) obtained by concept that SAPL is the vital load-bearing lubricant arthrocentesis were centrifuged to remove cellular debris and placed in vials containing 10 ml of chloroform, which were then sealed and shaken to extract biochemical degradation which could otherwise occur. elsewhere. Essentially, the inorganic phosphate is left (P < 0.005) after 16 h and significant (P < 0.01) after 32 h. The difference in proteolipid between test and behind in the aqueous phase during the chloroform extraction. All elemental phosphorus in the chloroform control joints was highly significant (P < 0.005) after 16 h, but not significant after 32 h. extract is then oxidized to phosphate using perchloric acid and estimated colorimetrically in a spectrophotometer set at 660 nm, using ammonium molybdate as DISCUSSION the indicator. Calibration was effected using dipalmit-
The results leave no doubt that a standard clinical oyl phosphatidylcholine (DPPC; Sigma Chemicals dose of MPA administered intra-articularly into the #P6267). DPPC was used as the standard because equine joint increases the quantity of SAPL in SF. phosphatidylcholine (PC ) is the major phospholipid This is clearly demonstrated by the 112% elevation of (PL) component of SF, while synovial PC is predomi-PL from pre-test levels ( Table I ) , which are similar to nantly saturated [17] . Each test was repeated and the those recorded in human SF [17] . It is also supported mean value recorded.
by the 239% rise in proteolipid. The apoproteins are Proteolipid was determined according to the method present in synovial surfactant in essentially the same of Bohlen et al. [18] as described in detail elsewhere.
proportions as found in the lung, these including Essentially, the test uses the residue remaining after surfactant protein 'A' [19] , and both SP-B and SP-C, evaporation of chloroform in which the proteolipid is which are proteolipids [11] . The role of proteolipid in co-extracted with PL. A known weight of this residue the alveolus is essentially one of facilitating adsorption is dispersed in sodium phosphate buffer at pH 8 with of the SAPL [20] and might also apply to the adsorpfluorescamine (Sigma # F-9015) in acetone as the tion of SAPL in the joint as the oligolamellar lining, indicator. This dispersion was analysed on a fluoresproviding lubrication and, possibly, other desirable cence spectrophotometer (Hitachi Perkin-Elmer Model properties outlined above. Proteolipid is also essential 203) at an emission wavelength of 475 nm with excitain the deposition of SAPL as myelin [21] whose tion at 365 nm. Calibration was performed using lamellated structure (and spacing) closely resembles bovine serum albumin (BSA) standards.
the outermost layers described on the articular surface [11] and elsewhere in the joint [10, 11, 22] . The fact RESULTS that proteolipid has also been identified in appreciable Phospholipid quantities in human SF in the ancillary experiment Phospholipid was found in significant quantities in supports its relevance to the human joint. all samples of SF in both the test (right) joint and
The increase of 112% in synovial surfactant followcontrol ( left) joint for all five horses. It was appreciably ing steroid injection is particularly interesting because higher in the test joint administered MPA in all horses SAPL is such an effective load-bearing lubricant [9], 16 h after injection; the results are summarized in which has been identified adsorbed to the articular Table I . It can be seen that the PL content of the test surface [9, 10]. Most of the improvement in mobility joints increased by 112% in comparison with 14% in of a patient administered steroids can be attributed to the control joints. The difference is also significant 32 h their anti-inflammatory action in reducing pain, but after injection.
enhanced lubrication could contribute. SAPL is also an excellent release (anti-stick) agent [23] which could Proteolipid help in initiating motion in a joint and preventing In one horse, there was insufficient sample remaining articular gelling, just as crude surfactant of biological after PL analysis for proteolipid determination. In the origin ( lecithin) is used for that purpose in many remaining four horses, proteolipid was present in all industrial processes. samples, as summarized in Table II . Proteolipid showed Another action of promoting surfactant secretion is a 3.4-fold rise in the test joints after 16 h in comparison that the enhanced lubricating lining, which imparts with a 23% fall in the control joints. such hydrophobicity to the articular surface [10, 11], could become a better barrier to water, reducing the
Statistical analysis
The paired t-test was used to compare PL in test hydration characteristic of degenerating cartilage [24] . In fact, DPPC has been shown to be an effective and control joints. The difference was highly significant SAPL to be a scavenger for these free radicals [29] .
of Health, 1985. In recent studies in this laboratory, it has been hydrophobic [14] . Hence, it is reasonable to speculate 35:821-7.
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